{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-25-000153","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.110439+00:00","generated_at":"2026-05-19T04:28:34.013197+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CEO Robert Spignesi diagnosed with treatable lymphoma; will continue to lead company","bullets":["CEO Robert Spignesi disclosed a recent diagnosis of a treatable form of lymphoma.","Treatment expected to last approximately four months; doctors gave a good prognosis.","Spignesi will continue to actively lead the business with limited in-person time and travel.","Board and leadership team are fully supportive of his continued role."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-25-000153","json":"https://secwatch.observer/filing/0001380106-25-000153.json","markdown":"https://secwatch.observer/filing/0001380106-25-000153.md","text":"https://secwatch.observer/filing/0001380106-25-000153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010625000153/0001380106-25-000153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010625000153/rpid-20250617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:28:34.013197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}